Cargando…

Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development

BACKGROUND: SSADH (aldehyde dehydrogenase 5a1 (Aldh5a1); γ-hydroxybutyric (GHB) aciduria) deficiency is a defect of GABA degradation in which the neuromodulators GABA and GHB accumulate. The human phenotype is that of nonprogressive encephalopathy with prominent bilateral discoloration of the globi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Erwin EW, Struys, Eduard, Jakobs, Cornelis, Hager, Elizabeth, Snead, O Carter, Gibson, K Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642797/
https://www.ncbi.nlm.nih.gov/pubmed/19040727
http://dx.doi.org/10.1186/1471-213X-8-112
_version_ 1782164654822260736
author Jansen, Erwin EW
Struys, Eduard
Jakobs, Cornelis
Hager, Elizabeth
Snead, O Carter
Gibson, K Michael
author_facet Jansen, Erwin EW
Struys, Eduard
Jakobs, Cornelis
Hager, Elizabeth
Snead, O Carter
Gibson, K Michael
author_sort Jansen, Erwin EW
collection PubMed
description BACKGROUND: SSADH (aldehyde dehydrogenase 5a1 (Aldh5a1); γ-hydroxybutyric (GHB) aciduria) deficiency is a defect of GABA degradation in which the neuromodulators GABA and GHB accumulate. The human phenotype is that of nonprogressive encephalopathy with prominent bilateral discoloration of the globi pallidi and variable seizures, the latter displayed prominently in Aldh5a1(-/- )mice with lethal convulsions. Metabolic studies in murine neural tissue have revealed elevated GABA [and its derivatives succinate semialdehyde (SSA), homocarnosine (HC), 4,5-dihydroxyhexanoic acid (DHHA) and guanidinobutyrate (GB)] and GHB [and its analogue D-2-hydroxyglutarate (D-2-HG)] at birth. Because of early onset seizures and the neurostructural anomalies observed in patients, we examined metabolite features during Aldh5a1(-/- )embryo development. METHODS: Embryos were obtained from pregnant dams sacrificed at E (embryo day of life) 10–13, 14–15, 16–17, 18–19 and newborn mice. Intact embryos were extracted and metabolites quantified by isotope dilution mass spectrometry (n = 5–15 subjects, Aldh5a1(+/+ )and Aldh5a1(-/-)) for each gestational age group. Data was evaluated using the t test and one-way ANOVA with Tukey post hoc analysis. Significance was set at the 95(th )centile. RESULTS: GABA and DHHA were significantly elevated at all gestational ages in Aldh5a1(-/- )mice, while GB was increased only late in gestation; SSA was not elevated at any time point. GHB and D-2-HG increased in an approximately linear fashion with gestational age. Correlative studies in human amniotic fluid from SSADH-deficient pregnancies (n = 5) also revealed significantly increased GABA. CONCLUSION: Our findings indicate early GABAergic alterations in Aldh5a1(-/- )mice, possibly exacerbated by other metabolites, which likely induce a heightened excitatory state that may predispose neural networks to epilepsy in these animals.
format Text
id pubmed-2642797
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26427972009-02-14 Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development Jansen, Erwin EW Struys, Eduard Jakobs, Cornelis Hager, Elizabeth Snead, O Carter Gibson, K Michael BMC Dev Biol Research Article BACKGROUND: SSADH (aldehyde dehydrogenase 5a1 (Aldh5a1); γ-hydroxybutyric (GHB) aciduria) deficiency is a defect of GABA degradation in which the neuromodulators GABA and GHB accumulate. The human phenotype is that of nonprogressive encephalopathy with prominent bilateral discoloration of the globi pallidi and variable seizures, the latter displayed prominently in Aldh5a1(-/- )mice with lethal convulsions. Metabolic studies in murine neural tissue have revealed elevated GABA [and its derivatives succinate semialdehyde (SSA), homocarnosine (HC), 4,5-dihydroxyhexanoic acid (DHHA) and guanidinobutyrate (GB)] and GHB [and its analogue D-2-hydroxyglutarate (D-2-HG)] at birth. Because of early onset seizures and the neurostructural anomalies observed in patients, we examined metabolite features during Aldh5a1(-/- )embryo development. METHODS: Embryos were obtained from pregnant dams sacrificed at E (embryo day of life) 10–13, 14–15, 16–17, 18–19 and newborn mice. Intact embryos were extracted and metabolites quantified by isotope dilution mass spectrometry (n = 5–15 subjects, Aldh5a1(+/+ )and Aldh5a1(-/-)) for each gestational age group. Data was evaluated using the t test and one-way ANOVA with Tukey post hoc analysis. Significance was set at the 95(th )centile. RESULTS: GABA and DHHA were significantly elevated at all gestational ages in Aldh5a1(-/- )mice, while GB was increased only late in gestation; SSA was not elevated at any time point. GHB and D-2-HG increased in an approximately linear fashion with gestational age. Correlative studies in human amniotic fluid from SSADH-deficient pregnancies (n = 5) also revealed significantly increased GABA. CONCLUSION: Our findings indicate early GABAergic alterations in Aldh5a1(-/- )mice, possibly exacerbated by other metabolites, which likely induce a heightened excitatory state that may predispose neural networks to epilepsy in these animals. BioMed Central 2008-11-28 /pmc/articles/PMC2642797/ /pubmed/19040727 http://dx.doi.org/10.1186/1471-213X-8-112 Text en Copyright © 2008 Jansen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jansen, Erwin EW
Struys, Eduard
Jakobs, Cornelis
Hager, Elizabeth
Snead, O Carter
Gibson, K Michael
Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development
title Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development
title_full Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development
title_fullStr Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development
title_full_unstemmed Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development
title_short Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development
title_sort neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (ssadh) deficiency suggest a heightened excitatory state during development
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642797/
https://www.ncbi.nlm.nih.gov/pubmed/19040727
http://dx.doi.org/10.1186/1471-213X-8-112
work_keys_str_mv AT jansenerwinew neurotransmitteralterationsinembryonicsuccinatesemialdehydedehydrogenasessadhdeficiencysuggestaheightenedexcitatorystateduringdevelopment
AT struyseduard neurotransmitteralterationsinembryonicsuccinatesemialdehydedehydrogenasessadhdeficiencysuggestaheightenedexcitatorystateduringdevelopment
AT jakobscornelis neurotransmitteralterationsinembryonicsuccinatesemialdehydedehydrogenasessadhdeficiencysuggestaheightenedexcitatorystateduringdevelopment
AT hagerelizabeth neurotransmitteralterationsinembryonicsuccinatesemialdehydedehydrogenasessadhdeficiencysuggestaheightenedexcitatorystateduringdevelopment
AT sneadocarter neurotransmitteralterationsinembryonicsuccinatesemialdehydedehydrogenasessadhdeficiencysuggestaheightenedexcitatorystateduringdevelopment
AT gibsonkmichael neurotransmitteralterationsinembryonicsuccinatesemialdehydedehydrogenasessadhdeficiencysuggestaheightenedexcitatorystateduringdevelopment